Transplanting retina using iPS cells to patients with intractable disease Apply for clinical research December 9 21:22
Announced that Kobe City's ophthalmology facility, etc. applied for a plan to conduct a new clinical study using iPS cells for patients with intractable disease called retinitis pigmentosa, a serious eye disease. Did. If the examination goes smoothly, we would like to carry out surgery during the next fiscal year.
“Kobe Eye Center Hospital” in Kobe City and RIKEN held a press conference on the 9th, and newly used iPS cells for patients with intractable disease called “retinal pigment degeneration”, a serious eye disease. Has announced that he has applied to a specialized committee of Osaka University.
There are about 40,000 patients with "retinal pigment degeneration" in Japan, but there is no effective treatment, so in clinical studies, transplanted retinas made from other people's iPS cells, It aims to restore the function of sensing light.
If the approval of the committee is obtained, the group will go through national examinations and aim to perform surgery during the next fiscal year.
Yasuo Kurimoto, head of the Kobe Eye Center Hospital, said, “I'm happy to take the first step. I hope it will be the hope of the patient who wants treatment.”